Our unique holistic approach reveals what is shifting, why it is shifting, and what actions will unlock value
By understanding why patients microdose and how it affects their mindset and outcomes, providers can offer more personalized care, correct misinformation, and build trust
That is the entire basis for the CagriSema combination therapy that has generated so much excitement in clinical trials
Reduces Distress Caused by Low Sexual Desire in Premenopausal Women With Hypoactive Sexual Desire Disorder In a review of data from two randomized phase 3 trials, researchers concluded that PT-141 was able to reduce distress related to low sexual desire in premenopausal women suffering from hypoactive sexual desire disorder (Kingsberg et al., 2019) [4]
10.1016/bs.mie.2018.04.012 3 BokoliyaS
Pulsatile growth hormone secretion pattern research